XTLB logo

XTL Biopharmaceuticals (XTLB)

Profile

Full Name

XTL Biopharmaceuticals Ltd.

Ticker Symbol

XTLB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Israel

IPO

September 1, 2005

Indexes

Not included

Website

http://www.xtlbio.com

Employees

8

Key Details

Price

$1.10(-2.65%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.30(-50.00% YoY)

PE ratio

-

Next earnings date

Apr 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.10
XTLB price is $1.10

30-Day Relative Volume

0.11
XTLB 30-day relative volume is 0.11

Price Performance

Price Today change

-2.65%
XTLB price is down -2.65% today

Price YTD change

-45.81%
XTLB price is down -45.81% since January 1st

Price 1-year change

-57.69%
XTLB price is down -57.69% year-on-year

Price 3-year change

-53.19%
XTLB price is down -53.19% over the past 3 years

Price Range

Price All-time high

$600.00
XTLB price is currently -99.82% below its historical high of $600.00

Price 3-year low

$0.75
XTLB price is currently +46.67% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$9.70M
XTLB market capitalization is $9.70 million

Market cap 3-year change

-24.29%
XTLB market capitalization is down -24.29% over the past 3 years

Market cap All-time high

$140.88M
XTLB market capitalization is currently -93.12% below its historical high of $140.88 million

Market cap sector rank

19.39%
XTLB market capitalization is higher than 19.39% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+61.75%
XTLB shares outstanding is up +61.75% year-on-year

Shares Outstanding 3-Year Change

+61.75%
XTLB shares outstanding is up +61.75% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.09
XTLB beta is 0.09

200-day SMA

$1.98
XTLB price is currently -44.55% below its 200-day simple moving average

50-day SMA

$1.34
XTLB price is currently -17.98% below its 50-day simple moving average

RSI

40.61
XTLB 14-day relative strength index is 40.61

Volume

0.11
XTLB 30-day relative volume is 0.11

ATR

$0.14
XTLB average true range is $0.14

10-day Historical Volatility

75.21%
XTLB 10-day historical volatility is 75.21%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
XTLB annual revenue value is unknown

Revenue Analysts estimate

-
XTLB annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
XTLB annual revenue 1-year change is unknown

Revenue Sector rank

-
XTLB annual revenue is unknown

EPS

EPS

-$0.30
XTLB annual earnings per share is -$0.30

EPS Analysts estimate

-
XTLB annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-50%
XTLB annual earnings per share is down -50% year-on-year

EPS Sector rank

74.81%
XTLB annual earnings per share is higher than 74.81% of companies in Healthcare sector

Profit

Gross profit

-
XTLB annual gross profit value is unknown

Gross margin

-
XTLB annual gross profit margin value is unknown

Operating profit

-$765.00K
XTLB annual operating income is -$765.00 thousand

Operating margin

-
XTLB annual operating profit margin value is unknown

Net income

-$1.78M
XTLB annual net profit is -$1.78 million

Net margin

-
XTLB annual net profit margin value is unknown

Expenses

Total expenses

$765.00K
XTLB annual total expenses is $765.00 thousand

Operating expenses

$765.00K
XTLB annual total operating expenses is $765.00 thousand

Cost of goods sold

-
XTLB annual cost of goods sold value is unknown

Selling, general & administrative expenses

$734.00K
XTLB annual SGA is $734.00 thousand

Depreciation and amortization

$0.00
XTLB annual depreciation & amortization is $0.00

Interest expense

-
XTLB annual interest expense value is unknown

Income tax

-
XTLB annual income tax value is unknown

EBIT & EBITDA

EBIT

-$765.00K
XTLB annual earnings before interest & taxes is -$765.00 thousand

EBITDA

-$765.00K
XTLB annual EBITDA is -$765.00 thousand

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$2.43M
XTLB annual total assets is $2.43 million

Non current assets

$380.00K
XTLB annual long term assets is $380.00 thousand

Current assets

$2.05M
XTLB annual total current assets is $2.05 million

Cash and cash equivalents

$1.40M
XTLB annual cash & cash equivalents is $1.40 million

Accounts receivable

-
XTLB annual accounts receivable value is unknown

Inventory

-
XTLB annual inventory value is unknown

Liabilities

Total liabilities

$206.00K
XTLB annual total liabilities is $206.00 thousand

Long term liabilities

$0.00
XTLB annual total long term liabilities is $0.00

Current liabilities

$206.00K
XTLB annual total current liabilities is $206.00 thousand

Accounts payable

$1000.00
XTLB annual accounts payable is $1000.00

Debt

Total debt

$0.00
XTLB annual total debt is $0.00

Total debt 1-year change

0%
XTLB {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
XTLB annual long term debt value is unknown

Short term debt

-
XTLB annual short term debt value is unknown

Equity & Capital

Shareholders equity

$2.22M
XTLB annual stockholders equity is $2.22 million

Book value

$2.22M
XTLB annual book value is $2.22 million

Retained earnings

-$158.25M
XTLB annual retained earnings is -$158.25 million

Working capital

$1.84M
XTLB annual working capital is $1.84 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$707.00K
XTLB annual cash flow from operations is -$707.00 thousand

Cash from operations 1-year change

+21.53%
XTLB annual cash flow from operations is up +21.53% year-on-year

Cash from investing

$41.00K
XTLB annual cash flow from investing activities is $41.00 thousand

Cash from investing 1-year change

+13.89%
XTLB annual cash flow from investing activities is up +13.89% year-on-year

Cash from financing

$0.00
XTLB annual cash flow from financing activities is $0.00

Cash from financing 1-year change

0%
XTLB {parameterFullLabel} has remained unchanged year-on-year

CAPEX

CAPEX

-
XTLB annual capital expenditures value is unknown

CAPEX 1-year change

-
XTLB annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$707.00K
XTLB annual free cash flow is -$707.00 thousand

Free cash flow 1-year change

+21.53%
XTLB annual free cash flow is up +21.53% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
XTLB annual gross profit margin value is unknown

Operating margin

-
XTLB annual operating profit margin value is unknown

Net margin

-
XTLB annual net profit margin value is unknown

ROA & ROE

ROA

-73.45%
XTLB annual return on assets is -73.45%

ROE

-80.27%
XTLB annual return on equity is -80.27%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
XTLB price to earnings ratio value is unknown

PE ratio Sector rank

-
XTLB price to earnings ratio is unknown

PB Ratio

PB ratio

1.70
XTLB price to book ratio is 1.70

PB ratio Sector rank

58.47%
XTLB price to book ratio is higher than 58.47% of companies in Healthcare sector

PS Ratio

PS ratio

59.85
XTLB price to sales ratio is 59.85

PS ratio Sector rank

93.21%
XTLB price to sales ratio is higher than 93.21% of companies in Healthcare sector

Enterprise value

Enterprise value

$9.04M
XTLB enterprise value is $9.04 million

Enterprise value Sector rank

24.03%
XTLB enterprise value is higher than 24.03% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-4521.65
XTLB EV/EBITDA is -4521.65

EV/EBITDA Sector rank

0%
XTLB EV/EBITDA is higher than 0% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

9.93
XTLB annual current ratio is 9.93

Quick ratio

-
XTLB annual quick ratio value is unknown

Leverage

Debt to equity

0.00
XTLB annual debt to equity ratio is 0.00

Interest coverage ratio

-
XTLB annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
XTLB piotroski f-score value is unknown

Altman Z-Score

-
XTLB altman z-score value is unknown

Analyst ratings

Recent major analysts updates

May 8, 15 HC Wainwright & Co.
Buy
May 8, 15 H.C. Wainwright
Buy

Institutional Ownership

Similar stocks

SNSE logo
Sensei Biotherapeutics (SNSE)
HCTI logo
Healthcare Triangle (HCTI)
ATHA logo
Athira Pharma (ATHA)
Kindly MD (KDLY)
MGRX logo
Mangoceuticals (MGRX)
RLMD logo
Relmada Therapeutics (RLMD)
EKSO logo
Ekso Bionics Holdings (EKSO)
HCWB logo
HCW Biologics (HCWB)
NeurAxis (NRXS)
  • What is the ticker symbol for XTL Biopharmaceuticals?
  • Does XTL Biopharmaceuticals pay dividends?
  • What sector is XTL Biopharmaceuticals in?
  • What industry is XTL Biopharmaceuticals in?
  • What country is XTL Biopharmaceuticals based in?
  • When did XTL Biopharmaceuticals go public?
  • Is XTL Biopharmaceuticals in the S&P 500?
  • Is XTL Biopharmaceuticals in the NASDAQ 100?
  • Is XTL Biopharmaceuticals in the Dow Jones?
  • When was XTL Biopharmaceuticals's last earnings report?
  • When does XTL Biopharmaceuticals report earnings?

What is the ticker symbol for XTL Biopharmaceuticals?

The ticker symbol for XTL Biopharmaceuticals is NASDAQ:XTLB

Does XTL Biopharmaceuticals pay dividends?

No, XTL Biopharmaceuticals does not pay dividends

What sector is XTL Biopharmaceuticals in?

XTL Biopharmaceuticals is in the Healthcare sector

What industry is XTL Biopharmaceuticals in?

XTL Biopharmaceuticals is in the Biotechnology industry

What country is XTL Biopharmaceuticals based in?

XTL Biopharmaceuticals is headquartered in Israel

When did XTL Biopharmaceuticals go public?

XTL Biopharmaceuticals's initial public offering (IPO) was on September 1, 2005

Is XTL Biopharmaceuticals in the S&P 500?

No, XTL Biopharmaceuticals is not included in the S&P 500 index

Is XTL Biopharmaceuticals in the NASDAQ 100?

No, XTL Biopharmaceuticals is not included in the NASDAQ 100 index

Is XTL Biopharmaceuticals in the Dow Jones?

No, XTL Biopharmaceuticals is not included in the Dow Jones index

When was XTL Biopharmaceuticals's last earnings report?

XTL Biopharmaceuticals's most recent earnings report was on Dec 31, 2024

When does XTL Biopharmaceuticals report earnings?

The next expected earnings date for XTL Biopharmaceuticals is Apr 30, 2025
On this page